Cited by 76Blood Pressure and Hypertension StudiesSodium Intake and HealthNutritional Studies and Diet

The DASH diet enhances the blood pressure response to losartan in hypertensive patients

Conlin, P·2003·American Journal of Hypertension

Abstract

BACKGROUND: The Dietary Approaches to Stop Hypertension (DASH) diet, which emphasizes fruits, vegetables, and low fat dairy products, significantly lowers blood pressure (BP). We conducted a clinical trial to assess the BP response to the DASH diet with an antihypertensive medication, losartan, in participants with essential hypertension. METHODS: A total of 55 hypertensive participants were randomly assigned to 8 weeks of controlled feeding with either a control diet or the DASH diet. Within each diet arm, participants received losartan 50 mg daily or placebo for 4 weeks each, in double blind, randomized, cross-over fashion. Twenty-four-hour ambulatory BP (ABP) was measured at the end of a 2-week run-in period (baseline) and after each 4-week intervention period. RESULTS: There was no significant change in ABP during the placebo period on the control diet (n = 28) (-2.3 +/- 1.5/-1.6 +/- 1.0 mm Hg), but there was a significant reduction in systolic ABP (-5.3 +/- 1.5 mm Hg, P <.05) and no change in DBP (-2.5 +/- 1.0 mm Hg) on the DASH diet (n = 27). Losartan significantly reduced ABP on the control diet (-6.7 +/- 1.5/-3.7 +/- 1.0 mm Hg, P <.05) and to a greater extent on the DASH diet (-11.7 +/- 1.5/-6.9 +/- 1.0 mm Hg, P <.05 versus basal and control diet) particularly in African Americans. On the DASH diet, DeltaSBP on losartan was inversely related to basal plasma renin activity (n = -0.53, P =.004). CONCLUSIONS: The DASH diet enhances the ABP response to losartan in essential hypertension. This effect is particularly marked in African Americans.

Integrity signals

Registry

Crossref · 10.1016/s0895-7061(03)00056-6

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The addition of healthy behaviors, such as a prudent diet and regular exercise, to either antihypertensive or lipid-lowering drug therapy in other populations reduced risk factors such as systolic and diastolic blood pressure, LDL cholesterol, and C-reactive protein compared with drug therapy alone.

    “The addition of healthy behaviors, such as a prudent diet and regular exercise, to either antihypertensive or lipid-lowering drug therapy in other populations reduced risk factors, such as systolic and diastolic blood pressure 33,34 and low-density lipoprotein cholesterol, 35 as well as the inflammatory biomarker C-reactive protein, 36 compared with drug therapy alone.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Conlin, P.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Conlin, P
Venue
American Journal of Hypertension
Published
2003-05
Volume
16
Issue
5
Pages
337-342
ISSN
0895-7061 (ISSN-L)
OpenAlex
W2007659191
Cited by
76
References
28
Citations by year
2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 8 · 2015: 3 · 2014: 3 · 2013: 2 · 2012: 3
FWCI
4.61
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Brigham and Women's Hospital (M01 RR02635)
  • Johns Hopkins University
  • National Institutes of Health (1u01hl057139-01, 1u01hl057173-01, RR‐02635, RR00722)
  • National Heart, Lung, and Blood Institute (HL 03857, HL57139, HL57114, HL57173)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK63214, K24DK063214)
  • National Center for Research Resources (M01 RR 02635, M01RR000722, M01-RR00722, M01RR002635)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
DASH diet, losartan, essential hypertension, blood pressure response, antihypertensive efficacy, plasma renin activity, African Americans, ambulatory blood pressure, dietary intervention, angiotensin receptor blockers
MeSH terms
Adult, Antihypertensive Agents, Blood Pressure, Circadian Rhythm, Diastole, Diet, Double-Blind Method, Female, Humans, Hypertension, Male, Middle Aged, Potassium, Renin, Systole, Biomarkers, Treatment Outcome, Cross-Over Studies, Losartan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review